---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-281051"
form_type: "8-K"
ticker: "KYMR"
cik: "0001815442"
company_name: "Kymera Therapeutics, Inc."
filed_at: "2026-06-24T20:07:58+00:00"
generated_at: "2026-06-24T20:09:27.141040+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Kymera annual meeting results: all Class III directors elected, say-on-pay approved, EY ratified

## Summary
- Elected Bruce Booth, Nello Mainolfi, John Maraganore, Elena Ridloff as Class III directors for 3-year terms.
- Advisory vote on named executive officer compensation passed with 74.9M for, 2.5M against, 26.6K abstain.
- Ratified Ernst & Young as independent auditor for FY2026 with 79.0M for, 38.1K against, 18.2K abstain.

## SEC filing metadata
- accession: 0001193125-26-281051
- form_type: 8-K
- ticker: KYMR
- cik: 0001815442
- company_name: Kymera Therapeutics, Inc.
- filed_at: 2026-06-24T20:07:58+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815442/000119312526281051/0001193125-26-281051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815442/000119312526281051/d131538d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-281051
- JSON: https://secwatch.observer/filing/0001193125-26-281051.json
- Plain text: https://secwatch.observer/filing/0001193125-26-281051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.